1 When nasal passages are blocked, nasal breathing can be more challenging, meaning it is harder to breathe through the nose
Studies have shown approximately 20% reduction in major adverse cardiovascular events
GLP-1 drug shows little benefit for people with Parkinsons disease 5 February 2025 The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinsons disease, finds a new study led by UCL researchers
Co-encapsulation of synthetic drugs and natural bioactive chemicals within the same PLGA nanoparticle system could have a synergetic therapeutic effect
The improvement of embryonic lethality upon L-carnitine supplementation and the demonstration of primary BB toxicity in our C elegans model provide important insights into treatment options for this condition
Persistent Gastrointestinal Symptoms : Inability to maintain adequate oral intake due to severe nausea or vomiting lasting more than 24-48 hours necessitates medical attention